Clinical trials present a new approach using immunotherapy

After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies could revolutionize the landscape of bladder cancer treatment.

Cancers, Free Full-Text

Clinical trial: New dual therapy could revolutionize treatment of urothelial and bladder cancers

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Immunotherapy for Mesothelioma: Success Rates & Side Effects

Delivery strategies of cancer immunotherapy: recent advances and future perspectives, Journal of Hematology & Oncology

New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase

New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase

Frontiers Clinical cancer immunotherapy: Current progress and prospects

A New Approach to Clinical Trials - ppt download

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials

Cancer Treatment Research: Importance of and Study Designs

A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is

INNOVATIONS IN CANCER TREATMENT

How Is Breast Cancer Treated?

Throat Cancer Treatment with Radiation Therapy - Short Version